Intravaginal ring delivery of tenofovir disoproxil fumarate for prevention of HIV and herpes simplex virus infection

Journal of Antimicrobial Chemotherapy

Volumn 67, Issue 7, 2012, Pages 1730-1738

  Mesquita, Pedro M M ^a   Rastogi, Rachna ^b   Segarra, Theodore J ^a   Teller, Ryan S ^b   Merna Torres, N ^a   Huber, Ashley M ^a   Kiser, Patrick F ^b,c   Herold, Betsy C ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b University of Utah   (United States)

^c UNIVERSITY OF UTAH   (United States)

Author keywords

Microbicides; NRTIs; PrEP

Indexed keywords

ACICLOVIR; ETHYLENE VINYL ACETATE COPOLYMER; POLYETHERURETHAN; SILICONE; TENOFOVIR; TENOFOVIR DISOPROXIL;

ANTIVIRAL ACTIVITY; ARTICLE; CELL GROWTH; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG POTENCY; DRUG RELEASE; DRUG SAFETY; DRUG STABILITY; EXPLANT; FEMALE; HERPES SIMPLEX; HERPES SIMPLEX VIRUS 2; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; INFECTION PREVENTION; NONHUMAN; POLARIZATION; SPERM; VAGINA RING; VIRUS INHIBITION;

ADENINE; ANTIVIRAL AGENTS; CELL CULTURE TECHNIQUES; CHEMOPREVENTION; CONTRACEPTIVE DEVICES, FEMALE; FEMALE; HERPES GENITALIS; HIV; HIV INFECTIONS; HUMANS; ORGAN CULTURE TECHNIQUES; PHOSPHONIC ACIDS; SIMPLEXVIRUS;

EID: 84862678558     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dks097     Document Type: Article

References (36)

1. Abdool Karim Q, Abdool Karim SS, Frohlich JA et al. Effectiveness and safety of tenofovir gel, an antiretroviral microbicide, for the prevention of HIV infection in women. Science 2010; 329: 1168-74.
2. Balzarini J, Holy A, Jindrich J et al. Differential antiherpesvirus and antiretrovirus effects of the (S) and (R) enantiomers of acyclic nucleoside phosphonates: potent and selective in vitro and in vivo antiretrovirus activities of (R)-9-(2-phosphonomethoxypropyl)-2,6-diaminopurine. Antimicrob Agents Chemother 1993; 37: 332-8.
3. Andrei G, Lisco A, Vanpouille C et al. Topical tenofovir, a microbicide effective against HIV, inhibits herpes simplex virus-2 replication. Cell Host Microbe 2011; 10: 379-89.
4. Herold BC, Mesquita PM, Madan RP et al. Female genital tract secretions and semen impact the development of microbicides for the prevention of HIV and other sexually transmitted infections. Am J Reprod Immunol 2011; 65: 325-33.
5. MTN. Microbicide Trials Network Statement on Decision to Discontinue Use of Tenofovir Gel in VOICE, a Major HIV Prevention Study in Women. http://www.mtnstopshiv.org/sites/default/files/attachments/MTNStatement Nov17DSMB_final.pdf (17 February 2012, date last accessed).
6. Smith DJ, Wakasiaka S, Hoang TD et al. An evaluation of intravaginal rings as a potential HIV prevention device in urban Kenya: behaviors and attitudes that might influence uptake within a high-risk population. J Womens Health (Larchmt) 2008; 17: 1025-34.
7. Johnson TJ, Gupta KM, Fabian J et al. Segmented polyurethane intravaginal rings for the sustained combined delivery of antiretroviral agents dapivirine and tenofovir. Eur J Pharm Sci 2010; 39: 203-12.
8. Malcolm RK, Edwards KL, Kiser P et al. Advances in microbicide vaginal rings. Antiviral Res 2010; 88 Suppl 1: S30-9.
9. Kiser PF, Johnson TJ, Clark JT. State of the art in intravaginal ring technology for topical prophylaxis of HIV infection. AIDS Rev 2012; 14: 62-77.
10. Martin DJ, Meijs GF, Gunatillake PA et al. The influence of composition ratio on the morphology of biomedical polyurethanes. J Appl Polym Sci 1999; 71: 937-52.
11. Fardis M, Oliyai R. Case study: tenofovir disoproxil fumarate: an oral prodrug of tenofovir. In: Borchardt RT and Middaugh CR, ed. Prodrugs: Challenges and Rewards. New York, USA: Springer, 2008; 1347-57.
12. Robbins BL, Srinivas RV, Kim C et al. Anti-human immunodeficiency virus activity and cellular metabolism of a potential prodrug of the acyclic nucleoside phosphonate 9-R-(2-phosphonomethoxypropyl) adenine (PMPA), bis(isopropyloxymethylcarbonyl)PMPA. Antimicrob Agents Chemother 1998; 42: 612-7.
13. Naesens L, Bischofberger N, Augustijns P et al. Antiretroviral efficacy and pharmacokinetics of oral bis(isopropyloxycarbonyloxymethyl)9-(2-phosphonylmethoxypropyl)adenine in mice. Antimicrob Agents Chemother 1998; 42: 1568-73.
14. Madan RP, Mesquita PMM, Cheshenko N et al. Molecular umbrellas: a novel class of candidate topical microbicides to prevent human immunodeficiency virus and herpes simplex virus infections. J Virol 2007; 81: 7636-46.
15. Mesquita PM, Wilson SS, Manlow P et al. Candidate microbicide PPCM blocks human immunodeficiency virus type 1 infection in cell and tissue cultures and prevents genital herpes in a murine model. J Virol 2008; 82: 6576-84.
16. Ejercito PM, Kieff ED, Roizman B. Characterization of herpes simplex virus strains differing in their effects on social behaviour of infected cells. J Gen Virol 1968; 2: 357-64.
17. Gupta KM, Pearce SM, Poursaid AE et al. Polyurethane intravaginal ring for controlled delivery of dapivirine, a nonnucleoside reverse transcriptase inhibitor of HIV-1. J Pharm Sci 2008; 97: 4228-39.
18. Clark MR, Johnson TJ, McCabe RT et al. A hot-melt extruded intravaginal ring for the sustained delivery of the antiretroviral microbicide UC781. J Pharm Sci 2012; 101: 576-87.
19. Herold BC, Siston A, Bremer J et al. Sulfated carbohydrate compounds prevent microbial adherence by sexually transmitted disease pathogens. Antimicrob Agents Chemother 1997; 41: 2776-80.
20. Greenhead P, Hayes P, Watts PS et al. Parameters of human immunodeficiency virus infection of human cervical tissue and inhibition by vaginal virucides. J Virol 2000; 74: 5577-86.
21. Mesquita PM, Cheshenko N, Wilson SS et al. Disruption of tight junctions by cellulose sulfate facilitates HIV infection: model of microbicide safety. J Infect Dis 2009; 200: 599-608.
22. Sangster J. Octanol-Water Partition Coefficients of Simple Organic Compounds. Gaithersburg, MD, USA: NIST, 1989.
23. Yuan LC, Dahl TC, Oliyai R. Degradation kinetics of oxycarbonyloxymethyl prodrugs of phosphonates in solution. Pharm Res 2001; 18: 234-7.
24. Zhu T, Mo H, Wang N et al. Genotypic and phenotypic characterization of HIV-1 patients with primary infection. Science 1993; 261: 1179-81.
25. Fletcher PS, Elliott J, Grivel JC et al. Ex vivo culture of human colorectal tissue for the evaluation of candidate microbicides. AIDS 2006; 20: 1237-45.
26. Lee H, Hanes J, Johnson KA. Toxicity of nucleoside analogues used to treat AIDS and the selectivity of the mitochondrial DNA polymerase. Biochemistry 2003; 42: 14711-9.
27. Tan DH, Kaul R, Raboud JM et al. No impact of oral tenofovir disoproxil fumarate on herpes simplex virus shedding in HIV-infected adults. AIDS 2011; 25: 207-10.
28. Hendrix C, Minnis A, Guddera V et al. MTN-001: a phase 2 cross-over study of daily oral and vaginal TFV in healthy, sexually active women results in significantly different product acceptability and vaginal tissue drug concentrations. In: Abstracts of the Eighteenth Conference on Retroviruses and Opportunistic Infections, Boston, MA, 2011. Paper # 35LB. Foundation for Retrovirology and Human Health, Alexandria, VA, USA.
29. Karim SS, Kashuba AD, Werner L et al. Drug concentrations after topical and oral antiretroviral pre-exposure prophylaxis: implications for HIV prevention in women. Lancet 2011; 378: 279-81.
30. Nel A, Smythe S, Young K et al. Safety and pharmacokinetics of dapivirine delivery from matrix and reservoir intravaginal rings to HIV-negative women. J Acquir Immune Defic Syndr 2009; 51: 416-23.
31. Sarkar NN. The combined contraceptive vaginal device (NuvaRing): a comprehensive review. Eur J Contracept Reprod Health Care 2005; 10: 73-8.
32. Kaur M, Gupta K, Poursaid A et al. Engineering a degradable polyurethane intravaginal ring for sustained delivery of dapivirine. Drug Deliv Transl Res 2011; 1: 223-37.
33. Johnson TJ, Albright TH, Clark MR et al. Long-term, time-independent release of the antiretroviral agent tenofovir in daily milligram quantities from an intravaginal ring. In: Abstracts of the Thirty-eighth Annual Meeting and Exposition of the Controlled Release Society, National Harbor, MD, 2011. Abstract no. 184. Controlled Release Society, St Paul, MN, USA.
34. Moscicki AB, Ma Y, Holland C et al. Cervical ectopy in adolescent girls with and without human immunodeficiency virus infection. J Infect Dis 2001; 183: 865-70.
35. Ballweber L, Robinson B, Kreger A et al. Vaginal Langerhans cells non-productively transporting HIV-1 mediate infection of T cells. J Virol 2011; 85: 13443-7.
36. Nuttall J, Kashuba A, Wang R et al. The pharmacokinetics of tenofovir following intravaginal and intrarectal administration of tenofovir gel to rhesus macaques. Antimicrob Agents Chemother 2012; 56: 103-9.